Onc Now: Cancer Vaccines and the Future of Immunotherapy

In this episode of Onc Now, Mary Disis, Director of the University of Washington's Medicine Cancer Vaccine Institute, Seattle, USA, explores the science and future of cancer vaccines. She discusses how vaccines fit into today's immunotherapy landscape, the evolution of human epidermal growth factor receptor 2 (HER2)-targeted therapies, progress in breast cancer vaccines, the promise of cancer prevention, and the key priorities for survivorship and future oncology care. Timestamps:  00:00 – Introduction 01:28 – Cancer Vaccines Explained 03:57 – Journey Into Cancer Immunology 06:38 – Cancer Vaccines in Immunotherapy 10:02 – Leading the Cancer Vaccine Institute 13:26 – Progress in Breast Cancer Vaccines 18:39 – HER2 Research and Treatment Evolution 21:30 – Future of Preventive Cancer Vaccines 26:39 – Priorities for Cancer Survivorship 30:30 – Three Wishes for Oncology's Future Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.